HAGE, a cancer/testis antigen expressed at the protein level in a variety of cancers

Tools

Mathieu, M.G., Linley, A.J., Reeder, S.P., Badoual, C., Tartour, E., Rees, R.C. ORCID: 0000-0002-4574-4746 and McArdle, S.E.B. ORCID: 0000-0001-6929-9782, 2010. HAGE, a cancer/testis antigen expressed at the protein level in a variety of cancers. Cancer Immunity, 10, p. 2.

Preview

Text
200351_6757 Mathieu Publisher.pdf
Download (2MB) | Preview

Abstract

The search for novel tumour antigens that are either uniquely expressed or over-expressed in a wide variety of tumours is still ongoing. Because of their expression in a broad spectrum of cancers and limited expression in normal tissues, cancer/testis antigens are considered to be potentially reliable targets for immunotherapy of cancer in general. The helicase antigen HAGE has been identified as a cancer/testis antigen. However, little is known about its expression in normal and cancer tissues. Using a newly developed antibody against HAGE, specific staining of its expression by immunohistochemistry was validated and optimised on murine tumours transfected to express the HAGE protein. The antibody was subsequently used to determine HAGE expression in normal human and cancer tissue microarrays. HAGE protein expression was confirmed in 75% (12/16) of carcinomas as compared to normal tissues, which either did not express HAGE at all or expressed HAGE at very low levels with the exception of testis. Interestingly, discrepancies were also found between mRNA analysis by real time quantitative PCR (RT-qPCR) and protein analysis by immunohistochemistry, emphasising the need to validate the expression of cancer/testis antigens at the protein level prior to the development of new vaccine strategies. HAGE is therefore proposed to be a valid candidate for designing a broad spectrum vaccine against cancer.

Item Type:	Journal article
Publication Title:	Cancer Immunity
Creators:	Mathieu, M.G., Linley, A.J., Reeder, S.P., Badoual, C., Tartour, E., Rees, R.C. and McArdle, S.E.B.
Publisher:	Academy of Cancer Immunology
Date:	2010
Volume:	10
Divisions:	Schools > School of Science and Technology
Record created by:	EPrints Services
Date Added:	09 Oct 2015 10:43
Last Modified:	11 Oct 2021 14:02
URI:	https://irep.ntu.ac.uk/id/eprint/17251